Impact of COVID-19 pandemic on the utilization and quality of antibiotic use in the primary care setting in England, March 2019–March 2023: a segmented interrupted time series analysis of over 53 million individuals
Open Access
- 1 July 2024
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 22 (12) , 1251-1262
Abstract
Amid the COVID-19 pandemic, we evaluated the short-term impact of COVID-19 on antibiotic use in primary care in England, focusing on both antibiotic quantity (overuse) and quality (misuse) of use. A population-based segmented interrupted analysis was applied on monthly dispensed antibiotics prescriptions using the Prescription Cost Analysis dataset (March/2019-March/2023). The quantity was assessed using number of items dispensed per 1000 inhabitants (NTI) and defined daily doses per 1000 inhabitants per day (DID), while quality was evaluated using WHO's Access Watch Reserve (AWaRe) classification, the proportion of '4C' antibiotics and the percentage of broad- to narrow-spectrum antibiotics. Findings indicate 8.6 (17.2%) and 0.4 (2.6%) increase in the NTI and DID, respectively, with a statistically significant uptick in trend noted after the second lockdown (β5) for 'total antibiotics' for NTI only (β5 = 1.6; 95% CI:0.17, 3.1). Quality assessment showed an increase in 'Access' antibiotics from 77% in March/2019 to 86% in March/2023; however, COVID-19 had no significant impact on WHO AWaRe classes. COVID-19's impact on antibiotic use quality and quantity appeared to be minimal, though an increase in utilization post-second lockdown coincided with healthcare system recovery. This suggests a nuanced impact of the pandemic, highlighting the importance of continued antimicrobial stewardship.Keywords
This publication has 39 references indexed in Scilit:
- The impact of COVID-19 on antibiotic prescribing in primary care in England: Evaluation and risk prediction of appropriateness of type and repeat prescribingJournal of Infection, 2023
- Antibiotic prescribing trends in primary care 2014–2022Research in Social and Administrative Pharmacy, 2023
- The WHO essential medicines list AWaRe book: from a list to a quality improvement systemClinical Microbiology and Infection, 2022
- Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European studyPharmacoepidemiology and Drug Safety, 2022
- Exposure to World Health Organization's AWaRe antibiotics and isolation of multidrug resistant bacteria: a systematic review and meta-analysisClinical Microbiology and Infection, 2022
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysisThe Lancet, 2022
- The Emerging Role of Telehealth in Antimicrobial Stewardship: A Systematic Review and PerspectiveCurrent Treatment Options in Infectious Diseases, 2021
- Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysisClinical Microbiology and Infection, 2021
- Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitalsJournal of Infection, 2020
- Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysisClinical Microbiology and Infection, 2020